Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 278

1.

Clinical trial design considerations in assessing long-term functional impacts of tiotropium in COPD: the UPLIFT trial.

Decramer M, Celli B, Tashkin DP, Pauwels RA, Burkhart D, Cassino C, Kesten S.

COPD. 2004;1(2):303-12.

PMID:
17136995
2.

Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.

Keam SJ, Keating GM.

Treat Respir Med. 2004;3(4):247-68. Review.

PMID:
15350163
4.

Tiotropium bromide, a new, once-daily inhaled anticholinergic bronchodilator for chronic-obstructive pulmonary disease.

ZuWallack AR, ZuWallack RL.

Expert Opin Pharmacother. 2004 Aug;5(8):1827-35. Review. Erratum in: Expert Opin Pharmacother. 2004 Sep;5(9):2051.

PMID:
15264997
5.

COPD in young patients: a pre-specified analysis of the four-year trial of tiotropium (UPLIFT).

Morice AH, Celli B, Kesten S, Lystig T, Tashkin D, Decramer M.

Respir Med. 2010 Nov;104(11):1659-67. doi: 10.1016/j.rmed.2010.07.016. Epub 2010 Aug 17.

6.

Impact of tiotropium on the course of moderate-to-very severe chronic obstructive pulmonary disease: the UPLIFT trial.

Tashkin DP.

Expert Rev Respir Med. 2010 Jun;4(3):279-89. doi: 10.1586/ers.10.23. Review.

PMID:
20524910
7.

[The UPLIFT study: future perspectives].

Rodríguez González-Moro JM, Lucero S, de Lucas Ramos P.

Arch Bronconeumol. 2008;44 Suppl 2:39-48. Spanish.

8.

[Efficacy of tiotropium bromide (Spiriva) in patients with chronic-obstructive pulmonary disease (COPD) of different severities].

Beeh KM, Beier J, Buhl R, Stark-Lorenzen P, Gerken F, Metzdorf N; ATEM-Studiengruppe.

Pneumologie. 2006 Jun;60(6):341-6. German.

PMID:
16761228
9.

Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial.

Aaron SD, Vandemheen KL, Fergusson D, Maltais F, Bourbeau J, Goldstein R, Balter M, O'Donnell D, McIvor A, Sharma S, Bishop G, Anthony J, Cowie R, Field S, Hirsch A, Hernandez P, Rivington R, Road J, Hoffstein V, Hodder R, Marciniuk D, McCormack D, Fox G, Cox G, Prins HB, Ford G, Bleskie D, Doucette S, Mayers I, Chapman K, Zamel N, FitzGerald M; Canadian Thoracic Society/Canadian Respiratory Clinical Research Consortium.

Ann Intern Med. 2007 Apr 17;146(8):545-55. Epub 2007 Feb 19.

PMID:
17310045
10.

Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator: a randomized trial.

Niewoehner DE, Rice K, Cote C, Paulson D, Cooper JA Jr, Korducki L, Cassino C, Kesten S.

Ann Intern Med. 2005 Sep 6;143(5):317-26.

PMID:
16144890
11.
12.

Eletrocardiographic monitoring in COPD patients receiving tiotropium.

Morganroth J, Golisch W, Kesten S.

COPD. 2004;1(2):181-90.

PMID:
17136986
13.
14.

Absence of electrocardiographic findings and improved function with once-daily tiotropium in patients with chronic obstructive pulmonary disease.

Covelli H, Bhattacharya S, Cassino C, Conoscenti C, Kesten S.

Pharmacotherapy. 2005 Dec;25(12):1708-18.

PMID:
16305289
15.
16.

Long-acting anticholinergic use in chronic obstructive pulmonary disease: efficacy and safety.

Tashkin DP.

Curr Opin Pulm Med. 2010 Mar;16(2):97-105. doi: 10.1097/MCP.0b013e328335df1e. Review.

PMID:
20019615
17.

Clinical course of chronic obstructive pulmonary disease: review of therapeutic interventions.

Anzueto A.

Am J Med. 2006 Oct;119(10 Suppl 1):46-53. Review.

PMID:
16996899
18.

Efficacy of tiotropium inhalation powder in african-american patients with chronic obstructive pulmonary disease.

Criner GJ, Sharafkhaneh A, Player R, Conoscenti CS, Johnson P, Keyser MT, Cassino C.

COPD. 2008 Feb;5(1):35-41. doi: 10.1080/15412550701815981.

PMID:
18259973
19.

The role of tiotropium bromide, a long-acting anticholinergic bronchodilator, in the management of COPD.

Saberi F, O'Donnell DE.

Treat Respir Med. 2005;4(4):275-81. Review.

PMID:
16086600
20.

A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease.

Casaburi R, Mahler DA, Jones PW, Wanner A, San PG, ZuWallack RL, Menjoge SS, Serby CW, Witek T Jr.

Eur Respir J. 2002 Feb;19(2):217-24.

Supplemental Content

Support Center